The U.S. biopharma and med-tech industries are adding their voice to that of Gilead Sciences Inc. in urging the California Supreme Court to review the Gilead Tenofovir Cases, which seek to hold the drug company liable for how and when it developed its pipeline of HIV drugs.
The American Tort Reform Foundation's (ATRF) "Judicial Hellholes" program, which reports on abuses in the civil justice system, has stated that a decision by a California Appellate Court in a lawsuit against Gilead Sciences could escalate the "tort tax" burden borne by California residents. The ATRF expressed apprehension that this trend might be adopted by the rest of the country.
The American Tort Reform Foundation's (ATRF) "Judicial Hellholes" program, which reports on abuses in the civil justice system, has stated that a decision by a California Appellate Court in a lawsuit against Gilead Sciences could escalate the "tort tax" burden borne by California residents. The ATRF expressed apprehension that this trend might be adopted by the rest of the country.